monitoring the aggressive drug regimens your patients are taking for rheumatoid arthritis

You'll see more emphasis on monitoring the aggressive drug regimens your patients are taking for rheumatoid arthritis.

These patients often end up on multiple meds to prevent joint damage...reduce disability...and improve long-term outcomes.

But these aggressive combinations of disease-modifying antirheumatic drugs (DMARDs) need to be closely watched.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote